Low-dose protocols (2.55 mg weekly) prioritize tolerability assessment and minimize nausea, constipation, and appetite suppression during the first 48 weeks
This precision approach reduces trial-and-error dosing and increases the likelihood of sustained weight loss success
Limited data support the use of other drugs, such as vasoactive intestinal peptide, nitric oxide donors (linsidomine), forskolin, potassium channel openers, moxisylyte or calcitonin gene-related peptide, usually combined with the main drugs [471,472]
Research suggests more vitamin D might ease depressive symptoms, including brain fog [27]
Investigated for metabolic effects associated with energy balance
The adipokine hypothesis of heart failure with a preserved ejection fraction